Marché mondial des intermédiaires API – Tendances et prévisions du secteur jusqu’en 2030

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Pharmaceutical Global Api Intermediates Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché mondial des intermédiaires API – Tendances et prévisions du secteur jusqu’en 2030

  • Pharmaceutical
  • Upcoming Reports
  • Sep 2023
  • Global
  • 350 Pages
  • Nombre de tableaux : 220
  • Nombre de figures : 60
Buy Now Acheter maintenant

Global Api Intermediates Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
 2023 –2030
Diagram Taille du marché (année de référence)
 USD 2.34 Billion
Diagram Taille du marché (année de prévision)
 USD 5.67 Billion
Diagram TCAC
 %
Diagram Principaux acteurs du marché
  • HIKAL Ltd
  • Cambrex Corporation
  • Ganesh Group
  • AlzChem Group AG
  • Vasudha Pharma

>Marché mondial des intermédiaires API, par type (intermédiaires de médicaments vétérinaires, intermédiaires pharmaceutiques/médicaments en vrac), produit (composé bromo, O-benzyl salbutamol, hémisulfate, oxirane, base de bisoprolol, PCBHP chiral, base de phéniramine, base de chlorphéniramine, base de bromphéniramine, base de mépyramine/pyrilamine, 6-amino-1,3-diméthyl uracile, théofylline, acéfylline, xanthine, nitriles, autres), type thérapeutique (maladies auto-immunes, oncologie, maladies métaboliques, ophtalmologie, maladies cardiovasculaires, maladies infectieuses, neurologie, troubles respiratoires, dermatologie, urologie, autres), clients (utilisateurs directs/sociétés pharmaceutiques, commerçants/grossistes/distributeurs, associations/institutions gouvernementales/institutions privées), utilisateur final (fabricant d'API, fabricant de produits finis), canal de distribution (direct) Appels d'offres, ventes au détail, autres) - Tendances et prévisions du secteur jusqu'en 2030.

Marché des intermédiaires API

Analyse et taille du marché mondial des intermédiaires API

Les principes actifs pharmaceutiques  sont des substances ou des combinaisons de substances destinées à être utilisées dans la fabrication d'un médicament qui, une fois utilisées dans la production du médicament, deviennent des principes actifs pharmaceutiques. Ces substances sont utilisées pour fournir une activité pharmacologique.             

Data Bridge Market Research analyse que le marché mondial des intermédiaires API, qui était de 2,34 milliards USD en 2022, devrait atteindre 5,67 milliards USD d'ici 2030 et devrait connaître un TCAC de 7,10 % au cours de la période de prévision 2023-2030. Les « intermédiaires pharmaceutiques/médicaments en vrac » dominent le segment type du marché mondial des intermédiaires API en raison de l'essor des industries pharmaceutiques. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse des pipelines, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché des intermédiaires API

Rapport métrique

Détails

Période de prévision

2023 à 2030

Année de base

2022

Années historiques

2021 (personnalisable pour 2015-2021)

Unités quantitatives

Chiffre d'affaires en millions USD, volumes en unités, prix en USD

Segments couverts

Type (intermédiaires de médicaments vétérinaires, intermédiaires pharmaceutiques / en vrac), produit (composé bromo, O-benzyl salbutamol, hémisulfate, oxirane, base de bisoprolol, PCBHP chiral, base de phéniramine, base de chlorphéniramine, base de bromphéniramine, base de mépyramine / pyrilamine, 6-amino-1,3-diméthyl uracile, théofylline, acéfylline, xanthine, nitriles, autres), type thérapeutique (maladies auto-immunes, oncologie, maladies métaboliques, ophtalmologie, maladies cardiovasculaires, maladies infectieuses , neurologie, troubles respiratoires, dermatologie, urologie, autres), clients (utilisateurs directs / sociétés pharmaceutiques, commerçants / grossistes / distributeurs, associations / institutions gouvernementales / institutions privées), utilisateur final (fabricant d'API, fabricant de produits finis), canal de distribution (appel d'offres direct, ventes au détail, Autres)

Pays couverts

États-Unis, Canada, Mexique, Allemagne, Royaume-Uni, France, Italie, Espagne, Pays-Bas, Russie, Suisse, Turquie, Autriche, Norvège, Hongrie, Lituanie, Irlande, Pologne, Reste de l'Europe, Japon, Chine, Australie, Inde, Corée du Sud, Singapour, Indonésie, Thaïlande, Malaisie, Philippines, Vietnam, Reste de l'Asie-Pacifique, Brésil, Argentine, Pérou, Reste de l'Amérique du Sud, Arabie saoudite, Afrique du Sud, Émirats arabes unis, Israël, Koweït, Égypte et Reste du Moyen-Orient et de l'Afrique

Acteurs du marché couverts
  • HIKAL Ltd. (Inde), Cambrex Corporation (États-Unis), Ganesh-Group, AlzChem Group AG (Inde), Vasudha Pharma (Inde), Anyang General Chemical Co., Ltd. (Chine), Sarex (Inde), Sandoo Pharmaceuticals and Chemicals Co., Ltd (Inde), Atul Ltd (Inde), Sandoz International GmbH (une filiale de Novartis AG) (Allemagne), Aceto (États-Unis), Supriya Lifescience Ltd. (Inde), LEVACHEM COMPANY LIMITED (Chine), Vertellus (États-Unis), Dishman Carbogen Amcis Ltd (Inde), Sanofi (France), Divi's Laboratories Limited (Inde), AARTI INDUSTRIES LIMITED (Inde), Aurobindo Pharma (Inde), BASF SE (Allemagne)

Opportunités de marché
  • Demande croissante de médecine personnalisée
  • Collaboration et partenariats en hausse
  • L'accent est mis de plus en plus sur la chimie verte et durable

Définition du marché

Lorsqu'on parle de médicaments et de synthèse chimique, le terme « intermédiaires API » fait référence aux nombreux composés chimiques et matériaux créés tout au long du long processus de synthèse d'un principe actif pharmaceutique (API). Les principes actifs (API) d'un médicament sont ceux qui lui confèrent son action thérapeutique. La création d'API implique souvent un certain nombre de réactions chimiques, de procédures de purification et de conversions d'ingrédients bruts en produit fini souhaité. Divers composés intermédiaires sont créés tout au long de ce processus, chacun agissant comme un tremplin vers l'API final. Ces intermédiaires peuvent avoir des caractéristiques chimiques, des structures et des applications uniques.

Dynamique du marché mondial des intermédiaires API

Conducteurs

  • Croissance de l'industrie pharmaceutique

Due to factors like ageing populations, rising healthcare costs, and the demand for novel and creative treatments, the pharmaceutical business is still growing globally. This expansion fuels the need for API intermediates, which are crucial ingredients in the production of pharmaceuticals.

  • Rising Technological Advancements

The efficiency and cost-effectiveness of the manufacturing of API intermediates are improved by developments in chemical synthesis and process technologies, thus fuelling market expansion.

  • Increasing Demand of Biopharmaceuticals

The need for bioprocess intermediates has expanded as a result of the rise in biopharmaceuticals such recombinant proteins and monoclonal antibodies. These steps in the process are necessary to produce biologics, which is helping to drive market growth.

Opportunities

  • Growing Demand of Personalized Medicine

The development of APIs and intermediates customised to particular patient profiles is required by the trend towards personalised medicine and targeted medicines, which can stimulate research and development in this field.

  • Rising Collaboration and Partnerships

Innovative solutions and access to new markets can result from collaboration between API intermediate producers, pharmaceutical firms, and research organisations.

  • Increasing Focus Towards Green and Sustainable Chemistry

There is a chance for API intermediate producers to create and deliver greener and more sustainable chemical processes and intermediates as sustainability and environmentally friendly practises receive increasing attention.

Restrains/ Challenges

  • Strict Regulations

In the pharmaceutical sector, strict regulatory regulations can be a major barrier. It can be expensive and time-consuming to comply with and keep up with rules like Good Manufacturing Practises (GMP) and limit market growth.

  • Supply Chain Disruptions

Due to the fact that many manufacturers rely on a complicated global network of suppliers for their raw materials and intermediates, the global API intermediates market is vulnerable to supply chain disruptions. The supply chain may be hampered by unforeseen circumstances like natural disasters or political unrest.

  • Safety Concerns

A top priority is to ensure the security of industrial procedures and the safety of employees. Hazardous substances and reactions can be used in the chemical synthesis process.

  • High Costs  

The cost-effectiveness and supply chain stability of the manufacturing of API intermediates can be affected by changes in the prices and availability of raw materials and chemicals.

This global API intermediates market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global API intermediates market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global API Intermediates Market Scope

The global API intermediates market is segmented on the basis of the type, product, therapeutic class, customers, end users and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Type

  • Veterinary Drug Intermediates
  • Pharmaceutical / Bulk Drug Intermediates

Product

  • Bromo Compound
  • O-Benzyl Salbutamol
  • Hemisulfate
  • Oxirane
  • Bisoprolol Base
  • Chiral PCBHP
  • Pheniramine Base
  • Chlorpheniramine Base
  • Brompheniramine Base
  • Mepyramine/pyrilamine Base
  • 6-Amino-1,3-Dimethyl Uracil
  • Theofylline
  • Acefylline
  • Xanthine
  • Nitriles
  • Others

Therapeutic Type

  • Autoimmune Diseases
  • Oncology
  • Metabolic Diseases
  • Ophthalmology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurology
  • Respiratory Disorders
  • Dermatology
  • Urology
  • Others

Customers

  • Direct Users/Pharma Companies
  • Traders/Wholesalers/Distributors
  • Associations/Govt. Institutions/Pvt Institutions

End Users

  • API Manufacturer
  • Finished Product Manufacturer

Distribution channel

  • Direct Tender
  • Retail Sales
  • Others

Global API Intermediates Market Regional Analysis/Insights

Global API intermediates market is analyzed and market size information is provided on the basis of the country, type, product, therapeutic type, customers, end user and distribution channel as referenced above.  

The countries covered in the global API intermediates market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

North America is dominating in the global API intermediates market and is expected to grow with the highest growth rate in the forecast period of 2023 to 2030 because of increasing healthcare expenditure and well-established healthcare infrastructure for the pharmaceutical / bulk drug intermediates segment.

L'Asie-Pacifique est à la tête de la croissance du marché mondial des intermédiaires API et le segment des intermédiaires pharmaceutiques/médicaments en vrac domine dans le pays en raison de l'augmentation de la disponibilité des intermédiaires API à moindre coût. Le segment des intermédiaires pharmaceutiques/médicaments en vrac en Allemagne domine le marché mondial des intermédiaires API en raison de la demande croissante de consommation pour les intermédiaires API.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, les actes réglementaires et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

 Le marché mondial des intermédiaires API vous fournit également une analyse de marché détaillée pour l'analyse des patients, le pronostic et les traitements. La prévalence, l'incidence, la mortalité et les taux d'adhésion sont quelques-unes des variables de données disponibles dans le rapport. L'analyse d'impact directe ou indirecte de l'épidémiologie sur la croissance du marché est analysée pour créer un modèle statistique multivarié de cohorte plus robuste pour prévoir le marché au cours de la période de croissance 2023-2030.

Analyse du paysage concurrentiel et des parts de marché des intermédiaires API

 Le paysage concurrentiel du marché mondial des intermédiaires API fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché mondial des intermédiaires API.

Certains des principaux acteurs opérant sur le marché mondial des intermédiaires API sont :

  • HIKAL Ltd. (Inde)
  • Cambrex Corporation (États-Unis)
  • Groupe Ganesh, AlzChem Group AG (Inde)
  • Vasudha Pharma (Inde)
  • Anyang Général Chemical Co., Ltd. (Chine)
  • Sarex (Inde)
  • Sandoo Pharmaceuticals and Chemicals Co., Ltd (Inde)
  • Atul Ltd (Inde)
  • Sandoz International GmbH (une filiale de Novartis AG) (Allemagne)
  • Aceto (États-Unis)
  • Supriya Lifescience Ltd. (Inde)
  • LEVACHEM COMPANY LIMITED (Chine)
  • Vertellus (États-Unis)
  • Dishman Carbogen Amcis Ltd (Inde)
  • Sanofi (France)
  • Divi's Laboratories Limited (Inde)
  • AARTI INDUSTRIES LIMITED (Inde)
  • Aurobindo Pharma (Inde)
  • BASF SE (Allemagne)

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL API intermediates MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
    1. CURRENT SCENARIO OF IMPORT AND EXPORT OF API INTERMEDIATE
    2. Tentative Production and operational costs calculations which will ultimately lead to feasibility of the product manufacturing
      1. Tentative Land requirement for a Substantial Production Capacity Plant Set-Up
    3. GLOBAL API INTERMEDIATES MARKET: 3C ANALYSIS-CHINA EFFECT
      1. THE U.S.-CHINA TRADE WAR
      2. INDO-CHINA GEOPOLITICAL ISSUES
      3. CHINESE SLOWDOWN DUE TO E&C OVER THE YEARS
      4. CHINESE SLOWDOWN DUE TO COVID-19 (CORONAVIRUS)
    4. Cost Analysis
    5. Analysis on China API intermediates:
      1. Conclusion:
    6. porters five forces model
    7. Pestel analysis
    8. global API INTERMEDIATES market: regulatORY
      1. THE U.S. REGULATORY GUIDANCE FOR NON-CLINICAL SAFETY EVALUATION OF API INTERMEDIATES
      2. CANADA REGULATORY GUIDANCE FOR API INTERMEDIATES
      3. EUROPE REGULATORY SCENARIO FOR API INTERMEDIATES
      4. JAPAN REGULATORY FOR API INTERMEDIATES
      5. MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR API INTERMEDIATES
  5. GLOBAL API INTERMEDIATES MARKET: CONCLUSION
    1. TOP PRODUCTS AND THERAPEUTIC AREAS
    2. ADDITIONAL
  6. CUSTOMER SENTIMENTS/INCLINATION TOWARDS FINDING ALTERNATE VENDOR SOURCE
  7. LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE:
  8. Market Overview
    1. Drivers
      1. HIGH BURDEN OF CHRONIC DISEASES
      2. increase in aging population
      3. utilization of advanceD technology in active pharmaceutical ingredients (api) manufacturing
      4. increasing disease awareness and education
      5. research and development regarding pharmaceutical API and their intermediates
    2. restrainTs
      1. availability of sub-standard and counterfeit drugs
      2. product recalls
      3. high manufacturing cost
      4. stringent government regulations for api intermediates
    3. opportunities
      1. strategic initiatives by the market players
      2. increasing healthcare expenditure
      3. SOARING NUMBER OF API INTERMEDIATES MANUFACTURERS
      4. RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
    4. challenges
      1. disruption in the supply chain of active pharmaceutical ingredients (api) during covid-19
      2. lack of workforce in pharma industries
  9. Impact of COVID 19 on Global API Intermediates market
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
    5. CONCLUSION
  10. global API intermediates MARKET, BY type
    1. overview
    2. pharmaceutical intermediates/ bulk drug intermediates
    3. Veterinary Drug Intermediates
  11. global API intermediates MARKET, BY product
    1. overview
    2. Nitriles
    3. bromo compound
    4. Chiral PCBHP
    5. Chlorpheniramine Base
    6. Brompheniramine Base
    7. Pheniramine Base
    8. O-Benzyl Salbutamol
    9. Bisoprolol Base
    10. Hemisulfate
    11. Oxirane
    12. Mepyramine/Pyrilamine Base
    13. Theofylline
    14. Acefylline
    15. Xanthine
    16. 6-Amino-1,3-Dimethyl Uracil
    17. others
  12. global API intermediates MARKET, BY therapeutic type
    1. overview
    2. Cardiovascular Diseases
    3. Metabolic Diseases
    4. infectious Diseases
    5. respiratory Diseases
    6. neurology
    7. oncology
    8. Autoimmune Disease
    9. Dermatology
    10. ophthalmology
    11. urology
    12. others
  13. global API intermediates MARKET, BY customers
    1. overview
    2. Direct Users/Pharma Companies
    3. Traders/Wholesalers/Distributors
    4. Associations/Govt. Institutions/Pvt Institutions
  14. global API intermediates MARKET, BY End User
    1. overview
    2. API manufacturer
    3. finished product manufacturer
  15. global API intermediates MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. Retail Sale
    4. others
  16. Global API Intermediates Market by geography
    1. Overview
    2. NORTH AMERICA
      1. U.S
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. U.K
      3. ITALY
      4. SPAIN
      5. FRANCE
      6. NETHERLANDS
      7. RUSSIA
      8. SWITZERLAND
      9. TURKEY
      10. AUSTRIA
      11. NORWAY
      12. HUNGARY
      13. LITHUANIA
      14. IRELAND
      15. POLAND
      16. REST OF ASIA PACIFIC
    4. ASIA-PACIFIC
      1. CHINA
      2. INDIA
      3. JAPAN
      4. AUSTRALIA
      5. SOUTH KOREA
      6. SINGAPORE
      7. MALAYSIA
      8. THAILAND
      9. INDONESIA
      10. PHILIPPINES
      11. VIETNAM
      12. REST OF ASIA PACIFIC
    5. SOUTH AMERICA
      1. BRAZIL
      2. ARGENTINA
      3. PERU
      4. REST OF SOUTH AMERICA
    6. MIDDLE EAST & AFRICA
      1. SAUDI ARABIA
      2. SOUTH AFRICA
      3. UAE
      4. ISRAEL
      5. KUWAIT
      6. EGYPT
      7. REST OF MIDDLE EAST & AFRICA
  17. Global API Intermediates Market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  18. swot analysis
  19. company profile
    1. aurobindo pharma
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORFOLIO
      5. RECENT DEVELOPMENTS
    2. Divi’s laboratories limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. basf se
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. CAMBRIX CORPORATION
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Sandoz International GmbH (a subsidiary of Novartis AG)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. aceto
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. hikal ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. alzchem group ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. vertellus
      1. COMPANY SNAPSHOT
      2. PRODUCT CATEGORIES
      3. RECENT DEVELOPMENTS
    10. sanofi
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    11. atul ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. aarti industries limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. vasudha pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. anyang general chemical co., Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    15. dishman carbogen amics ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    16. ganesh-group
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. levachem company limited
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    18. sandoo pharmaceuticals and chemicals co., ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. sarex
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. SUPRIYA LIFESCIENCE LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  20. questionnaire
  21. related reports

Liste des tableaux

TABLE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)

TABLE 2 Percentage Break up of Cost

TABLE 3 Tentative Land Requirement

TABLE 4 Percentage Break up of Plant Area

TABLE 5 Table: 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE

TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 7 MARKET PLAYERS OF API INTERMEDIATES

TABLE 8 Sales Data of API intermediates for 2019/2020

TABLE 9 Global API intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 10 Global pharmaceutical intermediates/ bulk drug intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 11 Global Veterinary Drug Intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 12 Global API intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 13 Global nitriles in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 14 Global bromo compound in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 15 Global chiral PCBHP in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 16 Global chlorpheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 17 Global brompheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 18 Global pheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 19 Global O-Benzyl Salbutamol in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 20 Global bisoprolol base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 21 Global hemisulfate in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 22 Global oxirane in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 23 Global mepyramine/pyrilamine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 24 Global theofylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 25 Global acefylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 26 Global Xanthine in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 27 Global 6-amino-1, 3-dimethyl uracil in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 28 Global others in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 29 Global API intermediates Market, By THERAPEUTIC Type, 2019-2028 (USD Million)

TABLE 30 globaL cardiovascular diseases in API intermediates Market, By Region, 2017-2028 (USD Million)

TABLE 31 globaL metabolic diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 32 globaLinfectious diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 33 globaL respiratory diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 34 globaL neurology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 35 globaL oncology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 36 globaL autoimmune diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 37 globaL dermatology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 38 globaL ophthalmology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 39 globaL urology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 40 globaL others in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 41 Global API intermediates Market, By CUSTOMERS, 2019-2028 (USD Million)

TABLE 42 globaL Direct Users/Pharma Companies in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 43 globaL Traders/Wholesalers/Distributors in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 44 globaL Associations/Govt. Institutions/Pvt Institutionsin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 45 Global API intermediates Market, By END USER, 2019-2028 (USD Million)

TABLE 46 Global API manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 47 Global finished product manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 48 Global API intermediates Market, By distribution channel, 2019-2028 (USD Million)

TABLE 49 globaL direct tender in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 50 globaL retail sales in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 51 globaL Othersin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 52 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 53 NORTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 54 North America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 55 North America API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 56 North America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 57 North America API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 58 North America API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 59 North America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 U.S API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 61 U.S API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 62 U.S API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 63 U.S API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 64 U.S API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 65 U.S API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 66 Canada API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 67 Canada API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 68 Canada API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 69 Canada API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 70 Canada API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 71 Canada API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 72 MEXICO API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 73 MEXICO API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 74 MEXICO API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 75 MEXICO API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 76 MEXICO API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 77 MEXICO API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 78 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 79 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 80 Europe API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 81 Europe API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 82 Europe API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 83 Europe API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 84 Europe API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 85 Germany API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 86 Germany API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 87 Germany API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 88 Germany API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 89 Germany API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 90 Germany API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 91 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 92 U.K API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 93 U.K API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 94 U.K API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 95 U.K API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 96 U.K API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 97 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 98 Italy API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 99 Italy API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 100 Italy API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 101 Italy API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 102 Italy API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 103 Spain API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 104 Spain API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 105 Spain API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 106 Spain API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 107 Spain API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 108 Spain API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 109 France API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 110 France API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 111 France API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 112 France API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 113 France API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 114 France API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 115 Netherlands API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 116 Netherlands API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 117 Netherlands API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 118 Netherlands API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 119 Netherlands API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 120 Netherlands API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 Russia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 122 Russia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 123 Russia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 124 Russia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 125 Russia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 126 Russia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 127 Switzerland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 128 Switzerland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 129 Switzerland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 130 Switzerland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 131 Switzerland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 132 Switzerland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 133 Turkey API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 134 Turkey API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 135 Turkey API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 136 Turkey API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 137 Turkey API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 138 Turkey API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 139 Austria API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 140 Austria API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 141 Austria API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 142 Austria API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 143 Austria API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 144 Austria API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 145 Norway API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 146 Norway API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 147 Norway API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 148 Norway API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 149 Norway API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 150 Norway API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 151 Hungary API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 152 Hungary API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 153 Hungary API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 154 Hungary API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 155 Hungary API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 156 Hungary API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 157 Lithuania API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 158 Lithuania API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 159 Lithuania API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 160 Lithuania API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 161 Lithuania API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 162 Lithuania API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 163 Ireland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 164 Ireland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 165 Ireland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 166 Ireland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 167 Ireland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 168 Ireland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 169 Poland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 170 Poland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 171 Poland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 172 Poland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 173 Poland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 174 Poland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 175 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 176 ASIA-PACIFIC API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 177 Asia-Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 178 Asia-Pacific API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 179 Asia-Pacific API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 180 Asia-Pacific API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 181 Asia-Pacific API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 182 Asia-Pacific API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 183 China API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 184 China API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 185 China API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 186 China API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 187 China API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 188 China API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 189 India API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 190 India API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 191 India API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 192 India API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 193 India API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 194 India API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 India API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 196 Japan API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 197 Japan API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 198 Japan API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 199 Japan API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 200 Japan API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 201 australia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 202 Australia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 203 Australia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 204 Australia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 205 Australia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 206 Australia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 207 South Korea API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 208 South Korea API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 209 South Korea API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 210 South Korea API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 211 South Korea API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 212 South Korea API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 213 Singapore API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 214 Singapore API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 215 Singapore API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 216 Singapore API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 217 Singapore API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 218 Singapore API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 219 Malaysia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 220 Malaysia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 221 Malaysia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 222 Malaysia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 223 Malaysia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 224 Malaysia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 225 Thailand API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 226 Thailand API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 227 Thailand API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 228 Thailand API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 229 Thailand API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 230 Thailand API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 231 Indonesia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 232 Indonesia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 233 Indonesia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 234 Indonesia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 235 Indonesia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 236 Indonesia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 237 Philippines API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 238 Philippines API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 239 Philippines API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 240 Philippines API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 241 Philippines API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 242 Philippines API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 243 Vietnam API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 244 Vietnam API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 245 Vietnam API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 246 Vietnam API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 247 Vietnam API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 248 Vietnam API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 249 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 250 SOUTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 251 South America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 252 South America API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 253 South America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 254 South America API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 255 South America API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 256 South America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 257 BRAZIL API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 258 BRAZIL API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 259 BRAZIL API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 260 BRAZIL API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 261 BRAZIL API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 262 BRAZIL API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 263 Argentina API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 264 Argentina API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 265 Argentina API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 266 Argentina API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 267 Argentina API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 268 Argentina API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 269 PERU API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 270 PERU API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 271 PERU API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 272 PERU API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 273 PERU API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 274 PERU API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 275 Rest of South America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 276 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 277 Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 278 Middle East & Africa API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 279 Middle East & Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 280 Middle East & Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 281 Middle East & Africa API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 282 Middle East & Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 283 Saudi Arabia API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 284 Saudi Arabia API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 285 Saudi Arabia API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 286 Saudi Arabia API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 287 Saudi Arabia API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 288 Saudi Arabia API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 289 South Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 290 South Africa API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 291 South Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 292 South Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 293 South Africa API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 294 South Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 295 UAE API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 296 UAE API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 297 UAE API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 298 UAE API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 299 UAE API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 300 UAE API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 301 Israel API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 302 Israel API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 303 Israel API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 304 Israel API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 305 Israel API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 306 Israel API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 307 Kuwait API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 308 Kuwait API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 309 Kuwait API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 310 Kuwait API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 311 Kuwait API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 312 Kuwait API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 313 Egypt API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 314 Egypt API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 315 Egypt API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 316 Egypt API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 317 Egypt API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 318 Egypt API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 319 Rest of Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

Liste des figures

FIGURE 1 Global API INTERMEDIATES MARKET: SEGMENTATION

FIGURE 2 GLOBAL API INTERMEDIATES MARKET: DATA TRIANGULATION

FIGURE 3 global API intermediates Market: DROC ANALYSIS

FIGURE 4 Global API intermediates market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global API intermediates Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL API intermediates MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL API intermediates MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL API INTERMEDIATES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL API INTERMEDIATES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL API intermediates MARKET: MARKET type COVERAGE GRID

FIGURE 11 Global API intermediates market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL API intermediates market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 north america is the fastest growing market FOR the API intermediates MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 Utilization of advanceD technology in active pharmaceutical ingredients (API) manufacturing is DRIVing THE global API intermediates MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 15 pharmaceutical / bulk drug intermediates SEGMENT is expected to account for the largest share of the global API INTERMEDIATES MARKET in 2021 & 2028

FIGURE 16 DRIVERS, RESTRAINTs, OPPORTUNITies AND CHALLENGEs OF Global API Intermediates market

FIGURE 17 TOP 5 COUNTRIES FOR NUMBER OF PEOPLE AGED 20 TO 79 SUFFERING FROM DIABETES in 2019

FIGURE 18 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN FEMALE POPULATION in 2020

FIGURE 19 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN MALE POPULATION in 2020

FIGURE 20 10 GLOBAL CAUSES OF DEATHs WITH THE CHRONIC DISEASES

FIGURE 21 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)

FIGURE 22 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)

FIGURE 23 global API intermediates market: BY type, 2021

FIGURE 24 global API intermediates market: BY type, 2019-2028 (USD Million)

FIGURE 25 global API intermediates market: BY type, CAGR (2021-2028)

FIGURE 26 global API intermediates market: BY type, LIFELINE CURVE

FIGURE 27 global API intermediates market: BY product, 2021

FIGURE 28 global API intermediates market: BY product, 2019-2028 (USD Million)

FIGURE 29 global API intermediates market: BY product, CAGR(2021-2028)

FIGURE 30 global API intermediates market: BY product, LIFELINE CURVE

FIGURE 31 global API intermediates market: BY therapeutic type, 2021

FIGURE 32 global API intermediates market: BY therapeutic type, 2019-2028 (USD Million)

FIGURE 33 global API intermediates market: BY therapeutic type, CAGR (2021-2028)

FIGURE 34 global API intermediates market: BY therapeutic type, LIFELINE CURVE

FIGURE 35 global API intermediates market: BY customers, 2021

FIGURE 36 global API intermediates market: BY customers, 2019-2028 (USD Million)

FIGURE 37 global API intermediates market: BY customers, CAGR (2021-2028)

FIGURE 38 global API intermediates market: BY customers, LIFELINE CURVE

FIGURE 39 global API intermediates market: BY end user, 2021

FIGURE 40 global API intermediates market: BY end user, 2019-2028 (USD Million)

FIGURE 41 global API intermediates market: BY end user, CAGR (2021-2028)

FIGURE 42 global API intermediates market: BY end user, LIFELINE CURVE

FIGURE 43 global API intermediates market: BY distribution channel, 2021

FIGURE 44 global API intermediates market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 45 global API intermediates market: BY distribution channel, CAGR (2021-2028)

FIGURE 46 global API intermediates market: BY distribution channel, LIFELINE CURVE

FIGURE 47 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: SNAPSHOT (2020)

FIGURE 48 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020)

FIGURE 49 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2021 & 2028)

FIGURE 50 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020 & 2028)

FIGURE 51 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY type (2021-2028)

FIGURE 52 North America API Intermediates market: SNAPSHOT (2020)

FIGURE 53 North America API Intermediates market: BY COUNTRY (2020)

FIGURE 54 North America API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 55 North America API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 56 North America API Intermediates market: BY type (2021-2028)

FIGURE 57 Europe API Intermediates market: SNAPSHOT (2020)

FIGURE 58 Europe API INTERMEDIATEs market: BY COUNTRY (2020)

FIGURE 59 Europe API INTERMEDIATEs market: BY COUNTRY (2021 & 2028)

FIGURE 60 Europe API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 61 Europe API Intermediates market: BY type (2021-2028)

FIGURE 62 Asia-Pacific API Intermediates market: SNAPSHOT (2020)

FIGURE 63 Asia-Pacific API Intermediates market: BY COUNTRY (2020)

FIGURE 64 Asia-Pacific API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 65 Asia-Pacific API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 66 Asia-Pacific API Intermediates market: BY type (2021-2028)

FIGURE 67 South America API Intermediates market: SNAPSHOT (2020)

FIGURE 68 South America API Intermediates market: BY COUNTRY (2020)

FIGURE 69 South America API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 70 South America API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 71 South America API Intermediates market: BY type (2021-2028)

FIGURE 72 Middle East & Africa API Intermediates market: SNAPSHOT (2020)

FIGURE 73 Middle East & Africa API Intermediates market: BY COUNTRY (2020)

FIGURE 74 Middle East & Africa API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 75 Middle East & Africa API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 76 Middle East & Africa API Intermediates market: BY type (2021-2028)

FIGURE 77 Global API Intermediates market: company share 2020 (%)

FIGURE 78 North America API Intermediates Market: company share 2020 (%)

FIGURE 79 EUROPE API Intermediates Market: company share 2020 (%)

FIGURE 80 ASIA-PACIFIC API Intermediates Market: company share 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The market is segmented based on Global API Intermediates Market, By Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) - Industry Trends and Forecast to 2030. .
The Global Api Intermediates Market size was valued at USD 2.34 USD Billion in 2022.
The Global Api Intermediates Market is projected to grow at a CAGR of 7.1% during the forecast period of 2023 to 2030.
The major players operating in the market include HIKAL Ltd, Cambrex Corporation, Ganesh Group, AlzChem Group AG, Vasudha Pharma, Anyang General Chemical Co., Sarex, Sandoo Pharmaceuticals and Chemicals Co., Atul Ltd, Sandoz International GmbH, Aceto, Supriya Lifescience , LEVACHEM COMPANY LIMITED, Vertellus, Dishman Carbogen Amcis Ltd, Sanofi, Divi's Laboratories Limited, AARTI INDUSTRIES LIMITED, Aurobindo Pharma, BASF SE.
The market report covers data from the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.

Parcourir les pages associées

Banner